Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Three European Scientists Awarded Medicine Prize

By Biotechdaily staff writers
Posted on 22 Jan 2003
The Louis-Jeantet Foundation for Medicine (Geneva, Switzerland) has announced that three innovative scientists in Europe have been awarded the foundation's 2003 Prize for Medicine. More...
The prize has been awarded every year since 1986 and its mission is to foster innovative biomedical research in Europe. Winners, who must be engaged in basic or clinical medical research, receive a cumulative award amounting to a maximum of 1.2 million euros to carry out their research projects, as well as a personal prize.

Wolfgang Baumeister, director of the Max-Planck Institute for Biochemistry (Martinsried, Germany), won for his work on the proteasome and for the further development of cryoelectron tomography. This method uses an electron microscope but analyzes objects in a rapidly frozen state that preserves their structure. With the prize, Prof. Baumeister proposes to push electron tomography to still higher resolution and to investigate the 3D architecture of the molecular complexes that form the synapses of nerve cells. Prof. Baumeister is a citizen of Germany.

Riitta Hari, a professor at the Academy of Finland and the head of the Brain Research Unit at the Low Temperature Laboratory of Helsinki University of Technology (Finland), won for her work in improving magnetoencephalography (MEG), which detects tiny changes in the magnetic field associated with brain activity. With the prize, Prof. Hari plans to study the effects of observed pain on brain activation of the observer, in order to contribute to our understanding of the neural basis of social cognition. Prof. Hari is a citizen of Germany.

Nikos Logothetis, director of the Max-Planck Institute for Biological Cybermetics and head of the department of physiology of cognitive processes in Tubingen (Germany), won for his progress in understanding the perception of visual images by the brain, working with trained monkeys. This led to the discovery that changes in local oxygenation, measured by functional magnetic resonance imaging (fMRI), are the result of incoming signals rather than outgoing action potentials. With the prize, he wants to develop new biochemical probes that detect neuronal activity in real-time. Prof. Logothetis is a citizen of Greece.




Related Links:
Max Planck, Martinsried
Helsinki U.
Max-Planck, Tubingen

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.